YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Injured by Geodon?
Geodon (Generic: Ziprasidone) has been linked to diabetes and other blood sugar side effects such as hyperglycemia. Part of the new class of atypical antipsychotic drugs, Geodon is used to treat patients with schizophrenia. On Aug 31, 2004, the FDA & Pfizer, the manufacturer of Geodon, warned doctors about the risk of developing high blood sugar and diabetes. The FDA asked Pfizer to add a new warning to the Geodon label warning patients that Geodon can cause diabetes and other blood sugar disorders. In a recent study, atypical antipsychotics similar to Geodon were found to cause diabetes 50% more often than older antipsychotic drugs. The atypical antipsychotic class of drugs includes Geodon, Zyprexa, Risperdal, Seroquel, Abilify and Clozaril.The FDA has become concerned about the possibility that Geodon / Ziprasidone and a number of other drugs might increase the possibility of a specific, potentially fatal heart-rhythm irregularity called torsade de pointes. The FDA did not approve Ziprasidone in 1998 because there was evidence that it could cause a lengthening of the so-called QT interval of the heartbeat, a change associated with torsade.
Additional Geodon side effects include: feeling unusually tired, nausea, constipation, dizziness, restlessness, diarrhea, rash, cough, runny nose, and abnormal muscle movements, including tremor, shuffling, and uncontrollable movements.
If you or a loved one took Geodon and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
GeodonRSS Feed
Pfizer Geodon Whistleblower Represented by Parker Waichman Alonso LLP
Sep 9, 2009 | Parker Waichman Alonso LLP
A whistleblower who was involved in last week's record breaking $2.3 billion Pfizer settlement was represented by the Great Neck, NY law firm of Parker Waichman Alonso LLP. The whistleblower lawsuit alleged that Pfizer illegally promoted the off-label use of the antipsychotic medication Geodon."We are proud of our client and the other relators who stepped forward to expose Pfizer's wrongdoing, and helped to make this settlement possible," said David Krangle, an attorney with Parker...
Pfizer's Illegal Promotion of Bextra and Other Drugs Results in Record Settlement, Guilty Plea
Sep 3, 2009 | Parker Waichman Alonso LLP
Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Company Inc., have agreed to pay a record-setting $2.3 billion to settle claims arising from the illegal marketing of some drugs. According to a U.S. Department of Justice press release, Pharmacia & Upjohn Company has also agreed to plead guilty to a felony violation regarding off-label promotions of the painkiller Bextra. Bextra was withdrawn from the market in 2005.As we've reported previously, doctors may...
Adult anti-psychotics can worsen troubles
May 2, 2006 | USA Today
Evan Kitchens, a cheerful fourth-grader who loves basketball and idolizes his 16-year-old brother, had been hospitalized for mental illness by the time he was 8. The boy from Bandera, Texas, was aggressive and hyperactive and had been diagnosed with a variety of other ailments, including obsessive-compulsive disorder and an autism spectrum disorder. A couple of years ago, Evan was taking five psychiatric drugs, says his mother, Mary Kitchens. Two were so-called atypical anti-psychotics, a...
New antipsychotic drugs carry risks for children
May 2, 2006 | USA Today
Nancy Thomas remembers the bad old days when she had to wear long-sleeve clothes to church to cover bite marks all over her arms from her daughter Alexa's rages. At age 8, Alexa was diagnosed with bipolar disorder. She was a violent child with sharp mood swings and meltdowns that drove her to tear up the house. Antidepressants and drugs for attention-deficit disorder had only made Alexa more aggressive, Thomas says. A mix of medicines including so-called atypical antipsychotics drugs approved...
Antipsychotic drug use among kids soars
May 2, 2006 | AP
The number of children taking antipsychotic medicines soared 73 percent in the four years ending in 2005, far outpacing the increase in adults, according to a Medco Health Solutions Inc. report released Tuesday. Use of the new class of drugs known as atypical antipsychotics by people 19 and younger skyrocketed 80 percent in the same time period, according to the pharmacy benefit manager. Antipsychotic drug prescriptions for that age group comprise a relatively small amount of the total for...
Geodon
Quick Facts
Geodon Reference Guide
Generic Name
Ziprasidone
Date Approved
February 5, 2001
Manufacturer
Pfizer
Status
On the market
Approved Uses
Schizophrenia
Serious Side Effects
Diabetes
Hyperglycemia
Blood sugar disorders
Abnormal muscle movements
Tremors
Premature death
Related Topics
Abilify
Clozaril
Risperdal
Seroquel
Zyprexa
Diabetes
Defective Drugs
Diseases
Ziprasidone
Date Approved
February 5, 2001
Manufacturer
Pfizer
Status
On the market
Approved Uses
Schizophrenia
Serious Side Effects
Diabetes
Hyperglycemia
Blood sugar disorders
Abnormal muscle movements
Tremors
Premature death
Related Topics
Abilify
Clozaril
Risperdal
Seroquel
Zyprexa
Diabetes
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS